| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $78.6M | +67.8% |
| R&D Expense | $189.1M | +15.1% |
| SG&A Expense | $55.0M | +25.6% |
| Operating Income | -$165.5M | -2.7% |
| Net Income | -$147.0M | +5.1% |
| EPS (Basic) | -$2.52 | +12.2% |
| EPS (Diluted) | -$2.52 | +12.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.0M | +60.8% |
| Accounts Receivable | $15.0M | — |
| Current Assets | $405.3M | -3.4% |
| Total Assets | $575.8M | -4.5% |
| Current Liabilities | $85.7M | +20.1% |
| Total Liabilities | $180.8M | +60.0% |
| Stockholders' Equity | $395.0M | -19.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$102.8M | +32.8% |
| Capital Expenditures | $34.5M | +1115.8% |
| Investing Cash Flow | $139.9M | +581.7% |
| Financing Cash Flow | $4.2M | -97.3% |
| Free Cash Flow | -$137.3M | +11.9% |